Trade AstraZeneca ^AZN

Healthy Returns: AstraZeneca, Pfizer, Gilead release cancer drug data

UK Stocks That Might Be Priced Below Estimated Value

Daiichi Sankyo, AstraZeneca Announce Promising DATROWAY Combination Data in NSCLC

AstraZeneca CEO on breast cancer drug trial: This is the future of cancer treatment

AstraZeneca pill helps cut breast cancer progression risk

Experimental AstraZeneca pill helps cut risk of breast cancer progression

Stock market update: Stocks that hit 52-week highs on NSE in today's trade

52 week high stocks: Stock market update: Stocks that hit 52-week lows on NSE in today's trade - The Economic Times

AstraZeneca Reports Encouraging Data For Enhertu As 1st-line Treatment Of HER2+ Breast Cancer

Stocks to watch today, June 2: Vi, Nykaa, IndiGo, Adani Energy, AstraZeneca | Markets News - Business Standard

Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June

The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development

AstraZeneca, Daiichi announce results from three trials on DATROWAY | Markets Insider

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI | Markets Insider

AstraZeneca announces results from SERENA-6 Phase III trial | Markets Insider

AstraZeneca breast cancer medicine slows disease by over six months

Blood test-guided treatment cuts breast cancer risk | Seymour Telegraph

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

First pivotal trial to demonstrate clinical value of monitor

AstraZeneca Breast Cancer Pill Slows Disease by Over Six Months

AstraZeneca Says Camizestrant Reduces Risk Of Disease Progression By 56% In SERENA-6 Phase III Trial

AstraZeneca PLC (NASDAQ:AZN) Position Increased by Wealth Enhancement Advisory Services LLC

Toronto Dominion Bank Acquires 9,151 Shares of AstraZeneca PLC (NASDAQ:AZN)

183,548 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

AstraZeneca PLC (NASDAQ:AZN) Short Interest Update

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia

Breast cancer: Pfizer-Arvinas drug beats AstraZeneca's in delaying disease's progression

AZN And Daiichi Sankyo's ENHERTU Shows Significant Survival Benefit In Phase 3 Gastric Cancer Trial

Versant Capital Management Inc Buys 8,562 Shares of AstraZeneca PLC (NASDAQ:AZN)

GTS Securities LLC Sells 41,000 Shares of AstraZeneca PLC (NASDAQ:AZN)

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial

AstraZeneca Reaches $51 Million Settlement in Pay-for-Delay Suit

AstraZeneca Share Price Today, AstraZeneca Stock Price Live NSE/BSE

AstraZeneca PLC (NASDAQ:AZN) Position Cut by Park National Corp OH

AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution | Markets News - Business Standard

Ostro: Aye To AI For Pharma Marketing, Nay To AI For Pharma Journalism 05/29/2025

Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests

Foreign firms deepen roots, strive for localization - Chinadaily.com.cn

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Danaher, AstraZeneca Form Partnership For Diagnostic Development | Morningstar

AstraZeneca Lung Cancer Treatment: AstraZeneca's Osimertinib Gains Expanded Approval for Lung Cancer Treatment in India, ETPharma

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Integrated Advisors Network LLC

AstraZeneca gets CDSCO nod for lung cancer drug

Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma

AstraZeneca receives CDSCO a pproval for Lung Cancer Drug

8,804 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Brucke Financial Inc.

Regulatory actions for May 28, 2025 | BioWorld

Foreign investment flourishes in Qingdao high-tech zone, boosting economic growth

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Mackenzie Financial Corp Raises Stake in AstraZeneca PLC (NASDAQ:AZN)

Sunbelt Securities Inc. Purchases 3,885 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Given Average Recommendation of "Buy" by Brokerages

AstraZeneca: Imfinzi Gets EU's CHMP Recommendation To Treat Muscle-Invasive Bladder Cancer

Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

Nvidia and Wallenberg businesses starting AI venture in Sweden

Smile Group appoints former AstraZeneca exec to lead healthtech venture builder

26,048 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Parr Mcknight Wealth Management Group LLC

Two Sigma Advisers LP Acquires Shares of 86,100 AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (AZN) Receives a Buy from Leerink Partners | Markets Insider

ENHERTU® (trastuzumab deruxtecan) Receives Time-Limited Reimbursement Recommendation from Canada's Drug Agency for Gastric Cancer

Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned

Principal Street Partners LLC Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Zacks Research Lowers Earnings Estimates for AstraZeneca

UK court clears the way for Amgen and Samsung to launch biosimilars

Astrazeneca's AZD-6793 arises as a promising therapeutic for COPD | BioWorld

Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27

Other news to note for May 21, 2025 | BioWorld

Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

AstraZeneca's Airsupra asthma treatment shows breakthrough results in trial

AstraZeneca Acquires EsoBiotec To Advance Instant IV-Delivered Cell Therapy For Cancer Treatment

Compugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call Transcript

Texas Bank & Trust Co Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (AZN) Trial: Airsupra Cuts Severe Asthma Risk by 47%

Tezepelumab Cuts Oral Corticosteroid Use in Severe Asthma

Cancer treatment paradigms in the precision medicine era

Soleus Capital Management L.P. Purchases Shares of 409,000 AstraZeneca PLC (NASDAQ:AZN)

Rafferty Asset Management LLC Buys 46,918 Shares of AstraZeneca PLC (NASDAQ:AZN)

Deutsche Bank AG Buys 6,039 Shares of AstraZeneca PLC (NASDAQ:AZN)

Combo Inhaler Better for Mild Asthma

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Strategic Wealth Partners Ltd.

Nomura Holdings Inc. Sells 127,159 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Pathstone Holdings LLC

Wuxi steps up biomedical excellence - Chinadaily.com.cn

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study

Netflix Stock Hits Record High: Could Netflix Stock Reach $1,400 in 2025?

USD/MXN Forecast: The US dollar has fallen against the Mexican peso

XRP Price Predictions: What’s Fueling the XRP Price Rally?

NXNN Stock Performance: Why NXNN Stock Gains Attention from Wall Street

Snowflake Stock Jumps on $250M AI Deal: Is SNOW a good stock to buy now?

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

AI Stock Analysis: PLTR Hits Record High as Government Deals Fuel Momentum

ACHR Stock Analysis: What’s Driving Archer Aviation's Market Performance?

Morning Note: ADP Jobs Report Eyed; BoC Rate Decision; ISM Services PMI

XRP Price Prediction: Where Will Ripple Price Be in June?

TEM stock price analysis: Why Tempus AI Stock Up Today?

Morning Note: CrowdStrike Reports; Gold Rises on Tensions; Dollar Falls Amid Trade Fears

Morning Note: Oil Jumps on Geopolitics; US JOLTs Eyed; USD/JPY Outlook

Morning Note: US-China Tensions Renew; ISM PMI Eyed; S&P 500, EURUSD Outlook